A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activity. by Wilschanski, Michael et al.
UCLA
UCLA Previously Published Works
Title
A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of 
proprotein convertase 1/3 and impairs its enzymatic activity.
Permalink
https://escholarship.org/uc/item/24f7d99q
Journal
PloS one, 9(10)
ISSN
1932-6203
Authors
Wilschanski, Michael
Abbasi, Montaser
Blanco, Elias
et al.
Publication Date
2014
DOI
10.1371/journal.pone.0108878
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
A Novel Familial Mutation in the PCSK1 Gene That Alters
the Oxyanion Hole Residue of Proprotein Convertase 1/3
and Impairs Its Enzymatic Activity
Michael Wilschanski1*, Montaser Abbasi1, Elias Blanco2,3, Iris Lindberg2, Michael Yourshaw3,
David Zangen4, Itai Berger5, Eyal Shteyer1, Orit Pappo6, Benjamin Bar-Oz7, Martin G. Martı´n3,
Orly Elpeleg8
1Gastroenterology Unit, Division of Pediatrics, Hadassah Hebrew University Hospital, Jerusalem, Israel, 2Department of Anatomy and Neurobiology, University of
Maryland-Baltimore, Baltimore, Maryland, United States of America, 3Department of Pediatrics, Division of Gastroenterology and Nutrition, Mattel Children’s Hospital and
the David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America, 4 Endocrinology Unit, Division of Pediatrics,
Hadassah Hebrew University Hospital, Jerusalem, Israel, 5Neurology Unit, Division of Pediatrics, Hadassah Hebrew University Hospital, Jerusalem, Israel, 6Department of
Pathology, Hadassah Hebrew University Hospital, Jerusalem, Israel, 7Department of Neonatology, Hadassah Hebrew University Hospital, Jerusalem, Israel, 8 Monique and
Jacques Roboh Department of Genetic Research, Hadassah Hebrew University Hospital, Jerusalem, Israel
Abstract
Four siblings presented with congenital diarrhea and various endocrinopathies. Exome sequencing and homozygosity
mapping identified five regions, comprising 337 protein-coding genes that were shared by three affected siblings. Exome
sequencing identified a novel homozygous N309K mutation in the proprotein convertase subtilisin/kexin type 1 (PCSK1)
gene, encoding the neuroendocrine convertase 1 precursor (PC1/3) which was recently reported as a cause of Congenital
Diarrhea Disorder (CDD). The PCSK1 mutation affected the oxyanion hole transition state-stabilizing amino acid within the
active site, which is critical for appropriate proprotein maturation and enzyme activity. Unexpectedly, the N309K mutant
protein exhibited normal, though slowed, prodomain removal and was secreted from both HEK293 and Neuro2A cells.
However, the secreted enzyme showed no catalytic activity, and was not processed into the 66 kDa form. We conclude that
the N309K enzyme is able to cleave its own propeptide but is catalytically inert against in trans substrates, and that this
variant accounts for the enteric and systemic endocrinopathies seen in this large consanguineous kindred.
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Introduction
Congenital diarrheal disorders (CDDs) are a group of devastat-
ing and potentially fatal neonatal enteropathies that often require
parenteral nutrition. Recently Canani et al. [1] proposed
classifying these disorders into 4 groups: 1) defects in digestion,
absorption, and transport of nutrients and electrolytes, such as
glucose-galactose malabsorption or sucrase-isomaltase deficiency,
caused by mutations in SLC5A1 [2] and SI [3] respectively; 2)
disorders of enterocyte differentiation and polarization, such as
microvillus inclusion disease and tufting enteropathy, caused by
mutations in MYO5B [4] and EPCAM [5] respectively; 3)
dysregulation of the intestinal immune response, as in immune
dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX)
syndrome caused by mutations in FOXP3 [6] and 4) defects of
enteroendocrine cell differentiation, as may be caused, for
example, by mutations in NEUROG3 [7]. These patients
frequently endure a complex and costly diagnostic odyssey that
often fails to produce a definitive diagnosis. Once infection is ruled
out, in most cases the disorder is found to be inherited in an
autosomal recessive manner; mutations in any of a large number
of genes may be responsible [8]. Identification of a causal mutation
can lead to improved management of the disease but genome-wide
screening for mutations has not yet entered standard practice [9].
Mild mutations in the PCSK1 gene (proprotein convertase
subtilisin/kexin type 1) are associated with obesity [10], and more
severe, rare mutations have increasingly been recognized as a
cause of malabsorptive diarrhea and other endocrinopathies in a
disorder called proprotein convertase 1/3 (PC1/3) deficiency
(OMIM: 600955) [11]. The enzyme encoded by PCSK1, the
neuroendocrine convertase 1 precursor, cleaves itself into the
active form, neuroendocrine convertase 1 (also called prohormone
convertase 1, proprotein convertase 1, and PC1), which is
responsible for processing multiple peptide hormones within the
enteroendocrine cell. Other rare heterozygous mutations in
PCSK1 have been observed in the general population, which
likely would be harmful in an individual with two damaged copies
of the gene [12]. PC1/3 deficiency involves a significant risk of
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mortality and failure to thrive secondary to severe generalized
malabsorptive diarrhea in early childhood. However, the require-
ment for parenteral nutritional support decreases after 18 months
of age, while various major systemic endocrinopathies develop
[9,11,13–15]. To date, 17 individuals in 15 families have been
reported to have disease-causing mutations in PCSK1. Thus
enteroendocrine cell dysfunction governs the early clinical
phenotype, while malabsorption may actually lessen the severity
of the obesity that develops at later ages. Growth hormone
deficiency, adrenal insufficiency, central diabetes insipidus, and
hypogonadism are commonly observed [11]. Here, we describe
four siblings with PC1/3 deficiency resulting from a novel
mutation in the PCSK1 gene.
Material and Methods
Subjects
The study was approved by the ethical IRB of Hadassah
Hebrew University Medical Center and the parents signed
informed consent.
Genomic DNA Isolation
Genomic DNA was extracted from blood by standard
procedures.
Linkage analysis
A search for common homozygous regions in the DNA samples
of affected patients was performed, using Affymetrix GeneChip
Human Mapping 250K Nsp Array, as previously described [16].
Whole exome analysis
Protein coding exon sequences were enriched in the DNA
sample of patient II-5 (fig. 1) using the SureSelect Human All
Exon 50 Mb Kit (Agilent Technologies, Santa Clara, CA, USA).
100 base, paired-end sequences were read by HiSeq2000
(Illumina, San Diego, CA, USA). Reads alignment and variant
calling were performed with DNAnexus software (Palo Alto, CA)
using the default parameters with the human genome assembly
hg19 (GRCh37) as a reference.
Transient transfection of expression vectors
A wild-type human PC1/3 (NP_000430.3)-encoding plasmid,
with a Flag-tag sequence inserted between the prodomain and the
catalytic domain, was mutated at residue Asn309 to encode Lys
(N309K AAC =.AAG; Genscript, Piscataway NJ) and verified by
sequencing in its entirety. No other mutations were present. The
wild-type and mutant plasmids were transiently transfected into
either HEK293 or Neuro2A cells using FuGene (Promega,
Madison WI); two days later, the overnight conditioned Optimem
(containing 100 mg/ml aprotinin) was assessed for protein
expression by Western blotting and was tested for enzymatic
activity using a fluorogenic substrate, pERTKR-AMC (Peptides
International, Lexington, KY), as previously described [11–12].
Pulse-chase experiments. Neuro2A cells were transfected
with either wild-type or mutant PC1/3 vectors and labeled with
35S-methionine for 20 min, as described in Blanco et al. [17]. Cells
were then chased for 2 h in medium containing cold methionine
and lysed in boiling buffer for immunoprecipitation using N-
terminal PC1/3 antisera (2B5) plus C-terminal PC1/3 antisera
(3BF), and chase media were also immunoprecipitated. Immuno-
precipitates were separated on 15% SDS-polyacrylamide gels,
dried, and subjected to phosphoimaging.
Histology
Small bowel mucosal biopsies from subjects II-2 and II-5 were
stained by standard hematoxylin and eosin.
Results
Clinical Phenotype
Following one early first trimester miscarriage, four children
were born at normal birth weight to healthy parents, who were
first cousins of Moslem Arab ethnicity. The first child (II-2)
developed severe malabsorptive diarrhea during first week of life
with steatorrhea but without evidence of a protein-losing
enteropathy (Fig. 1). Various dietary manipulations were attempt-
ed including hydrosylate and amino acid based formulae which
failed. She was started after the first month of life on parenteral
nutrition (PN), which was continued until five years of age.
A residual metabolic acidosis, resulting most probably from the
chronic diarrhea, was treated by bicarbonate until eight years of
age. Repeated small intestinal biopsies showed non-specific
enteropathy including mild villous atrophy, slight increase in
number of intraepithelial lymphocytes, and chronic inflammation
of lamina propria (Fig. 2). The usual serologies indicative of celiac
disease were undetectable.
Initially her relatively low FT4 levels were attributed to sick
euthyroid syndrome, but as they persisted into her second year of
life in spite of an improving clinical condition she was diagnosed
with mild central hypothyroidism (TSH levels of 2–3 mIU/ml
despite low free T4 levels of 7–9 pmol/l) and received thyroid
replacement therapy. Given her poor growth rate and decreased
peak GH response in 2 stimulation tests (only 3.5 and 6.5 ng/ml)
by 3–4 years of age she did also receive GH replacement therapy
that resulted in adequate growth rate with a height of 156 cm at
12 years of age and breast and pubic hair development at Tanner
stage 3–4.
Other remitting endocrinopathies included self-limited episodes
of diabetes insipidus (DI) with polyuria, a low urine osmolarity
(70–150 mOsm/l), and elevated serum osmolarity (.300 mOsm/
l). These episodes ended spontaneously with a short course of
intranasal desmopressin (ddAVP) treatment. Finally, a gradual
weight gain was initially attributed to a better appetite. However,
she became increasingly severely obese by six years of age (Body
Mass Index (BMI) –21.6), (50th percentile 15.4) and continued to
become more obese despite adequate GH and thyroid replace-
ment, and intensive nutritional therapeutic guidance. Her
neurologic development is normal and she has no convulsive
disorder.
The two subsequent sisters (II-3, 4) were born after uneventful
pregnancies and deliveries, but died at 9 days and 5 months of age
respectively suffering from intractable seizures with left hemi-
sphere rhythmic epileptiform activity by EEG. MR/MRS (at the
age of 5 months) revealed periventricular white matter volume loss
with ventricular dilatation. The second of these children had also
recurrent episodes of diarrhea and hypothyroidism, and were
treated with PN and thyroxine. Brain ultrasound scan in this infant
was normal. The seizures were of multiple type (mainly clonic and
myoclonic types) and unresponsive to all anti-epileptic drugs in
various combinations. Both epileptic patients have neither
permanent electrolyte nor metabolic imbalances associated with
diarrhea. Epilepsy is an unexpected finding in patients with CDD
especially in the absence of significant electrolyte or metabolic
imbalances.
The youngest sibling (II-5) is now a one-year-old male who was
born at normal birth weight following an uneventful pregnancy.
He presented with neonatal diarrhea reminiscent of his two older
Proprotein Convertase 1/3 Deficiency Caused by Novel PCSK1 Variant
PLOS ONE | www.plosone.org 2 October 2014 | Volume 9 | Issue 10 | e108878
sisters and required home PN for one year. No endocrinopathies
or convulsive disorders have been found thus far and his small
bowel biopsy showed only non-specific changes.
Sequencing/Bioinformatics
The normal intestinal absorption of patient II-3, who suffered
from severe epilepsy, suggested the presence of two non-linked
disorders in the family, intractable diarrhea and drug-resistant
epilepsy, both of which may have been transmitted in an
autosomal-recessive manner, given the parental consanguinity.
In order to identify the diarrhea-causing gene, we genotyped 250K
SNPs in patients II-2 and II-4 who had intractable diarrhea and in
patient II-3 who had normal bowel movement. This analysis
resulted in the identification of five homozygous regions (Table 1)
where the SNP genotype of patients II-2 and II-4 was identical and
differed from that of patient II-3.
These regions encompassed 337 protein-coding genes and we
therefore opted for whole exome sequencing of the DNA of patient
II-5. The average coverage of the exons within the linked regions
was 63X and 97.1% of the exons were covered .7X. Altogether
we found 1089 missense or indel variants (only 46 of which were
homozygous) that were not present in dbSNP version 129 or in the
in-house dbSNP. Only four missense variants were located within
the shared homozygosity blocks (Table 2).
One of these variants, the N309K mutation in the PCSK1 gene,
appeared to be the probable cause of the CDD and endocrinop-
athies, given that other mutations in PCSK1 are known to cause
similar symptoms, whereas the other three variants (HADHA,
FBXL17 and GTF3C2) are not known to be involved in CDD.
The N309K mutation in the PCSK1 gene was predicted to be
deleterious by multiple in silico methods: SIFT [18] , PolyPhen2
[19], LRT [20], MutationAssessor [21], MutationTaster [22],
Condel [23], and CAROL [24]. The mutation was not reported in
the 1092 genomes of the 1000 Genomes project [25] nor in the
6503 exomes in the NHLBI Exome Sequencing project [26]
(Table 2) Moreover the probability of splicing changes due to the
intronic variants in FBXL17 and GTF3C2 was predicted to be
low. Interestingly, the rare, but predicted as deleterious HADHA
variant is associated with long-chain 3-hydroxyl-CoA dehydroge-
nase (LCHAD) deficiency (OMIM: 609016), but malabsorptive
diarrhea is not associated with this condition.
The enzyme encoded by PCSK1, prohormone convertase 1/3
(PC1/3), processes latent precursors to peptide hormones into
their biologically active products within the enteroendocrine cell.
The Asn residue at position 309 in the PC1/3 active site (the
Figure 1. Family Pedigree. Pedigree showing intractable diarrhea (green) and seizures (red) and other clinical phenotypes. A slash through the
symbol indicates that the subject is deceased, and a double line between the parents indicates a consanguineous union.
doi:10.1371/journal.pone.0108878.g001
Figure 2. H&E staining of small bowel biopsies from patients II-
2 and II-5. A) Mild villous atrophy associated with a slight increase in
number of intraepithelial lymphocytes, and mild chronic inflammation
of lamina propria (electron microscopy not shown-normal microvillous
architecture); B) the villi appear normal without lymphocytic abnor-
malities in the intraepithelial and lamina propria compartments.
Moreover, very few plasma cells were seen, and the epithelium was
devoid of abnormal apoptosis, or abnormalities of microvilli.
doi:10.1371/journal.pone.0108878.g002
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peptidase S8 family domain) is conserved in all vertebrates (Fig 3).
Sanger sequencing of other affected and unaffected family
members confirmed that this mutation segregated in the family,
with patients II-2, II-4 and II-5 being homozygous and the parents
(I-1 and I-2) and patient II-3 heterozygous (Fig 4).
Functional Analysis and In Vitro Assessment
The position of this mutation corresponds to a residue critical to
proprotein maturation and enzyme activity, the oxyanion hole
transition state-stabilizing amino acid Asn309. To validate the
functional significance of this rare variant, we expressed the wild
type and the mutant PC1/3 protein in HEK293 and Neuro2A
cells and tested its activity. Western blotting indicated that the
N309K mutant protein exhibited apparently normal prodomain
Table 1. Homozygous regions linked to the enteric disease in the family.
chromosome start end size (Mb)
2 18294643 30607011 12.31
3 178985197 190692992 11.71
5 89679361 109389770 19.71
10 87890424 95523820 7.63
13 19625269 24664802 5.04
doi:10.1371/journal.pone.0108878.t001
Table 2. Homozygous variants within the diarrhea-linked regions of patient II-5.
Gene HADHA GTF3C2 PCSK1 FBXL17
CHROM 2 2 5 5
POS 26453084 27566454 95746646 107521954
ID rs71441018 rs112001928 - -
REF C A G G
ALT G G C A
Transcript ENST00000380649 ENST00000359541 ENST00000311106 ENST00000542267
cDNA c.652G.C c.-24-9T.C c.927C.G c.1615-6C.T
Protein p.Val218Leu - p.Asn309Lys -
Exon 7/20 intron 1/18 8/14 intron 5/8
Amino acid 218/763 -/911 309/753 -/701
Consequence missense_variant intron_variant missense_variant splice_region_variant,
intron_variant
Gene name hydroxyacyl-CoA
dehydrogenase/3-ketoacyl-
CoA thiolase/enoyl-CoA
hydratase (trifunctional
protein), alpha subunit
general transcription
factor IIIC, polypeptide
2, beta 110kDa
proprotein convertase
subtilisin/kexin type 1
F-box and leucine-rich
repeat protein 17
OMIM LCHAD deficiency (609016;
Trifunctional protein
deficiency (609015)
- Obesity and endocrinopathy
due to impaired processing
of prohormones (600955)
-
CAROL24 deleterious(1) - deleterious(1) -
Condel23 deleterious(0.842) - deleterious(1) -
LRT20 deleterious(1.03E-08) - deleterious(1.25E-10) -
Mutation Assessor21 medium(2.76) - high(4) -
Mutation Taster22 disease causing(1) disease causing(0.98) disease causing(1) disease causing(0.85)
PolyPhen219 probably_damaging(0.999) - probably_damaging(1) -
SIFT18 deleterious(0.01) - deleterious(0) -
African American
AF(hom)*
0(0/2203) 0.003(0/2203) 0(2203) -
European American
AF(hom)*
0.000465(0/4300) 0.023(3/4297) 0(4300) -
* Allele frequency (number of homozygous individuals) in the Exome Variant Server, NHLBI Exome Sequencing Project (ESP)26.
REF – GRCh37 reference allele, ALT – variant allele, OMIM – Online Mendelian Inheritance in Man36.
doi:10.1371/journal.pone.0108878.t002
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removal and was efficiently secreted from both HEK293 and
Neuro2A cells (Fig 5). However, the secreted enzyme showed no
catalytic activity (panels A1–B1) and was not processed into the
66 kDa form independently of cell context (panels A2–B3),
indicating no in trans activity.
In order to better assess prodomain removal, we performed
radiolabeling experiments of PCSK1-transfected Neuro 2A cells.
Fig 5, Panel C shows that the N309K mutant underwent only
slight prodomain removal (prodomain = 94 kDa form; mature
form = 87 kDa) within the 20 minute pulse period, but showed
complete prodomain removal within the 2 h chase period in
media samples. In agreement with the Western blots, the mature
87 kDa mature form of the N309K mutant was secreted. These
results contrast with results obtained using the G593R PCSK1
mutant, which is totally unable to remove its own propeptide and
is retained in the endoplasmic reticulum [15]. In lysate samples
from Neuro2A transfected cells, the G593R proprotein was
unreactive against the M1 Flag antiserum (which is specific for N-
terminal Flag sequences) but reacted with the M2 Flag antiserum
which recognizes internal Flag sequences, while the N309K
protein reacted with both antisera (panel D). These data
corroborate the removal of the propeptide in N309K-transfected
cells.
Discussion
The natural history of these children is consistent with the
emerging clinical phenotype of proprotein convertase 1/3
deficiency, which typically involves CDD and an array of systemic
endocrinopathies that develop in an age-dependent manner [11].
Neonates have severe generalized malabsorptive diarrhea and
failure to thrive, and require prolonged total parenteral nutrition.
As the disease progresses additional endocrine abnormalities
develop, including diabetes insipidus, growth hormone deficiency,
primary hypogonadism, adrenal insufficiency, and hypothyroid-
ism. Moderate obesity, associated with severe polyphagia,
generally appears despite early growth abnormalities. Patient II-
2 required parenteral nutrition, and was diagnosed with diabetes
insipidus, hypothyroidism and developed obesity in concordance
with this disease phenotype [11].
In approximately 10–15% of infants who suffer from severe
neonatal seizures the etiology is unknown, and it is assumed that
these patients have genetic encephalopathies [27]. Several studies
have elucidated the pathogenic role of genetic mutations involved
in synaptogenesis, pruning, neuronal migration and differentia-
tion, neurotransmitter synthesis and release, and structure and
function of membrane receptors and transporters, but PCSK1
variants have not been associated with a significant neurologic
impairment [28–29].
PCSK1 point mutations associated with PC1/3 deficiency result
in the absence or significant reduction of secreted PC1/3
enzymatic activity similar to that observed here [9,11–12].
However, the mutation presented herein, unlike previous reported
cases, resulted in a secreted enzyme in which the propeptide was
removed but no activity was present against synthetic substrates.
The catalytic triad in eukaryotic subtilases consists of His-Ser-Asp;
in addition, an Asn residue, which occupies a catalytic pocket site
known as the oxyanion hole, is thought to stabilize the transition
state of the product in both bacterial and eukaryotic subtilases
[30]. Nearly all eukaryotic subtilases contain an Asn in this
position; however, the prohormone convertase PC2 contains an
Asp at this site. Substitution of the oxyanion hole Asn for Asp in
the yeast subtilase kex2 resulted in a marked decrease in enzymatic
activity [31]. However, substitution of the unusual Asp in PC2
with Asn did not result in measurable changes in enzyme activity
[32], suggesting some flexibility in the oxyanion hole residue
within prohormone convertases. By contrast, substitution of other
catalytic residues in either PC1/3 or PC2 results in lack of
prodomain removal, lack of secretion, and consequent loss of
enzymatic activity [32–34].
Figure 3. Alignment of N309K missense variant to members of
the PC1/3 gene family. The location of the missense mutation within
a conserved region in the catalytic domain of the PC1/3 gene family.
doi:10.1371/journal.pone.0108878.g003
Figure 4. Sanger sequencing validation of the N309K variant. Sanger sequencing of the results for the proband, parent and unaffected
control at nucleotide position 5: 95746646.
doi:10.1371/journal.pone.0108878.g004
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The fact that the N309K mutant undergoes slowed prodomain
removal implies that the identity of the oxyanion hole residue
contributes to this intramolecular cleavage event. Interestingly,
normal prodomain removal of a mouse PC1/3 N309D mutant
was observed in in vitro translational experiments; in this work,
potential effects of this substitution on enzymatic activity using
other substrates were not studied [35].
We conclude that replacing the oxyanion hole residue (N309) by
Asp [35]. or Lys (this study) does not suppress prodomain removal,
and PC1/3 continues to traffic through the secretory pathway.
Nevertheless, the complete loss of activity of the resultant mature
Figure 5. Lack of activity of N309K PC1/3 despite robust secretion. PC/3-encoding vectors were transfected into HEK (A panels, left side) or
Neuro2A cells (B panels, right side) and the conditioned media subjected to either enzymatic assay (A1, B1) using the standard fluorogenic assay; or to
Western blotting using PC1/3 antiserum (A2, B2). Cell extracts were also subjected to Western blotting (A3, B3). Panel C shows the maturation of 35S-
methionine-labeled wild-type and N309K precursor proteins during a 20-minute pulse followed by a 2 h chase in Neuro2A cells. WT, wild-type PC1/3.
Panel D shows a Western blot of Neuro2A cell lysate, previously transfected with either N309K and G593R PC1/3 cDNAs and incubated with a-FLAG
M1 or a-FLAG M2 antibodies to discriminate the 94 kDa PC1/3 prodomain ER-retained form.
doi:10.1371/journal.pone.0108878.g005
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mutant enzyme supports a critical role for the oxyanion hole
residue in intermolecular substrate catalysis. The total absence of
the PC1/3 66 kDa form in the medium secreted from Neuro2A
cells transfected with the N309K mutant corroborates the idea
that this PC1/3 variant is unable to cleave its own C-terminal
domain in the usual intermolecular interaction [36]. These
unequivocal effects on enzyme activity would be expected to
result in the loss of all PC1/3-mediated processing in patients with
this oxyanion substitution.
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